Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 01/21/2028 | CALL | $70.00 | 4,271 | +150 | +3.64% |
| 05/15/2026 | CALL | $75.00 | 2 | +1 | +100.00% |
| 05/15/2026 | CALL | $80.00 | 17 | +1 | +6.25% |
| 05/15/2026 | CALL | $85.00 | 3 | +1 | +50.00% |
| 05/15/2026 | PUT | $60.00 | 3 | +1 | +50.00% |
| 04/17/2026 | CALL | $35.00 | 0 | 0 | |
| 01/21/2028 | PUT | $90.00 | 0 | 0 | |
| 01/21/2028 | PUT | $95.00 | 0 | 0 | |
| 01/21/2028 | PUT | $100.00 | 3 | 0 | |
| 01/21/2028 | PUT | $105.00 | 0 | 0 | |
| 01/21/2028 | PUT | $110.00 | 0 | 0 | |
| 01/21/2028 | PUT | $115.00 | 0 | 0 |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.96% | 2.18M | 87.61M |
| Vanguard Small-Cap Index Fund | 2.51% | 1.85M | 74.35M |
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 2.45% | 1.81M | 72.62M |
| Fidelity Select Portfolios - Biotechnology | 2.20% | 1.62M | 65.1M |
| iShares Russell 2000 ETF | 2.09% | 1.55M | 62.06M |
| Hartford Mid Cap Fund | 1.90% | 1.4M | 56.17M |
| Vanguard Specialized-Health Care Fund | 1.67% | 1.24M | 49.62M |
| Delaware Group Equity Fds V-Small Cap Core Fund | 1.48% | 1.1M | 43.98M |
| Vanguard Small-Cap Growth Index Fund | 1.45% | 1.07M | 42.97M |
| Vanguard Extended Market Index Fund | 1.32% | 976.77k | 39.22M |
What's Going On With Royalty Pharma Stock Wednesday?
12/31 11:47 am
Benzinga
Read moreRoyalty Pharma Acquires Remaining Royalty Interest in Roche's Evrysdi for $240 Million and Potential Milestones
12/29 05:40 pm
Benzinga
Read moreNovartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income guidance
07/17 01:00 am
GlobeNewswire Inc.
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
06/02 01:55 pm
GlobeNewswire Inc.
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
06/02 01:52 pm
GlobeNewswire Inc.
Read moreRNA Targeting Small Molecule Drug Discovery Research Report 2025 - Global $5.52 Bn Market Trends, Opportunities, and Forecasts, 2020-2030F
05/29 10:56 am
GlobeNewswire Inc.
Read moreEvolving Landscape of Mitochondrial Disease Market: Key Insights of Latest Published Report—Leigh Syndrome, Leber’s Hereditary Optic Neuropathy, MELAS Syndrome, and Thymidine Kinase 2 Deficiency | DelveInsight
05/26 01:00 pm
GlobeNewswire Inc.
Read morePTC Therapeutics, Inc. (PTCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek ... - GlobeNewswire
07/09 02:01 pm
GlobeNewswire Inc.
Read morePTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug
07/01 08:00 am
Zacks Investment Research
Read morePTC Therapeutics (PTCT) Soars 9.7%: Is Further Upside Left in the Stock?
06/24 04:44 am
Zacks Investment Research
Read moreThe Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics
05/24 09:38 am
Zacks Investment Research
Read moreBiotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
05/23 12:46 pm
Zacks Investment Research
Read morePTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug
05/21 12:26 pm
Zacks Investment Research
Read moreCompared to Estimates, PTC Therapeutics (PTCT) Q1 Earnings: A Look at Key Metrics
04/25 08:00 pm
Zacks Investment Research
Read morePTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
04/18 10:01 am
Zacks Investment Research
Read moreBiotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
03/21 10:01 am
Zacks Investment Research
Read morePTC Therapeutics (PTCT) Up on Positive Regulatory Updates
03/20 02:00 pm
Zacks Investment Research
Read moreCooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
03/01 12:18 pm
Benzinga
Read moreHere's What Key Metrics Tell Us About PTC Therapeutics (PTCT) Q4 Earnings
02/29 07:00 pm
Zacks Investment Research
Read morePTC Therapeutics (PTCT) Reports Q4 Loss, Lags Revenue Estimates
02/29 06:20 pm
Zacks Investment Research
Read moreWall Street's Insights Into Key Metrics Ahead of PTC Therapeutics (PTCT) Q4 Earnings
02/26 10:16 am
Zacks Investment Research
Read moreWill Karyopharm Therapeutics (KPTI) Report Negative Q4 Earnings? What You Should Know
02/14 11:00 am
Zacks Investment Research
Read morePTC Therapeutics (PTCT) to Report Q4 Results: Wall Street Expects Earnings Growth
02/13 11:00 am
Zacks Investment Research
Read more1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock?
02/11 02:45 am
The Motley Fool
Read moreStrength Seen in Enanta Pharmaceuticals (ENTA): Can Its 13.8% Jump Turn into More Strength?
01/05 04:09 am
Zacks Investment Research
Read moreBiogen's (BIIB) Rare Disease Drug Skyclarys Gets CHMP Nod in EU
12/18 10:57 am
Zacks Investment Research
Read moreSolid Biosciences' (SLDB) DMD Drug Gets Fast Track Tag, Stock Up
12/08 06:37 am
Zacks Investment Research
Read moreEntrada (TRDA) Down on FDA Maintaining Clinical Hold on DMD Drug
11/23 12:47 pm
Zacks Investment Research
Read moreAnalyst Expectations for PTC Therapeutics's Future
11/20 11:00 am
Benzinga
Read moreSolid Biosciences (SLDB) Stock Up as FDA Clears DMD Drug IND
11/16 09:29 am
Zacks Investment Research
Read morePinterest Primed for Rich Ad Spend; Adobe a Powerhouse: Street Calls of the Week
10/29 09:46 am
Investing.com
Read moreAmazon To Rally Around 55%? Here Are 10 Top Analyst Forecasts For Friday
10/27 08:06 am
Benzinga
Read moreThe Zacks Analyst Blog Highlights Bristol Myers, PTC Therapeutics, Beam Therapeutics and BioMarin Pharmaceutical
10/27 07:15 am
Zacks Investment Research
Read morePTC Therapeutics (PTCT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
10/26 07:30 pm
Zacks Investment Research
Read morePTC Therapeutics (PTCT) Reports Q3 Loss, Lags Revenue Estimates
10/26 05:30 pm
Zacks Investment Research
Read moreBiotech Stock Roundup: BMY's Q3 Results, PTCT Up on Deal, BEAM's Restructuring News
10/26 11:28 am
Zacks Investment Research
Read moreNeurocrine Biosciences (NBIX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
10/24 10:00 am
Zacks Investment Research
Read moreWhy PTC Therapeutics Soared 15% Higher Today
10/19 07:02 pm
The Motley Fool
Read moreNasdaq Falls 100 Points; AT&T Posts Upbeat Earnings
10/19 02:37 pm
Benzinga
Read morePTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
10/19 10:01 am
Zacks Investment Research
Read moreAT&T, Union Pacific, Las Vegas Sands And Other Big Stocks Moving Higher On Thursday
10/19 09:56 am
Benzinga
Read morePTC Therapeutics stock jumps on royalty deal worth up to $1.5 billion
10/19 09:18 am
MarketWatch
Read morePTC Therapeutics (PTCT) Moves 5.3% Higher: Will This Strength Last?
10/11 08:07 am
Zacks Investment Research
Read moreBenzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
10/06 11:00 am
Benzinga
Read morePTC Therapeutics (PTCT) to Cut 25% Jobs by January 2024
09/29 11:18 am
Zacks Investment Research
Read moreBiotech Stock Roundup: GSK's Drug Approval, MRNA's Vaccine News, PTCT & SPRY Down
09/21 10:43 am
Zacks Investment Research
Read morePTC Therapeutics (PTCT) Surges 5.8%: Is This an Indication of Further Gains?
09/20 04:00 am
Zacks Investment Research
Read more